FOLFIRI

FOLFIRI is a chemotherapy regimen for treatment of colorectal cancer. It is made up of the following drugs:

Cetuximab, a monoclonal antibody to epidermal growth factor receptor, is sometimes added to FOLFIRI.[1]

The regimen consists of:

This cycle is typically repeated every two weeks. The dosages shown above may vary from cycle to cycle.

Also see

References

  1. ^ NEJM 360:1408